The importance of clinical trial data sharing: toward more open science.
作者信息
Ross Joseph S, Lehman Richard, Gross Cary P
机构信息
Section of General Internal Medicine, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
出版信息
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):238-40. doi: 10.1161/CIRCOUTCOMES.112.965798.
Abstract
摘要
相似文献
1
The importance of clinical trial data sharing: toward more open science.
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):238-40. doi: 10.1161/CIRCOUTCOMES.112.965798.
2
IOM outlines framework for clinical data sharing, solicits input.
JAMA. 2014 Feb 19;311(7):665. doi: 10.1001/jama.2014.884.
3
Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health models.
Sci Data. 2023 Aug 8;10(1):529. doi: 10.1038/s41597-023-02436-0.
4
Leveraging Open Science to Accelerate Research.
N Engl J Med. 2021 Apr 29;384(17):e61. doi: 10.1056/NEJMp2034518. Epub 2021 Mar 24.
5
Clinical trial data: share and share alike?
JAMA. 2015 Mar 3;313(9):881-2. doi: 10.1001/jama.2015.481.
6
Sharing and reporting the results of clinical trials.
JAMA. 2015 Jan 27;313(4):355-6. doi: 10.1001/jama.2014.10716.
7
Dissemination of the Results of Pediatric Clinical Trials Funded by the US National Institutes of Health.
JAMA. 2023 Feb 21;329(7):590-592. doi: 10.1001/jama.2022.24025.
8
Time for NIH to lead on data sharing.
Science. 2020 Mar 20;367(6484):1308-1309. doi: 10.1126/science.aba4456.
9
IRBs, data sharing, and privacy of human subjects.
Hum Res Rep. 2002 Apr;17(4):3.
10
Data Sharing for Pediatric Clinical Trials Funded by the US National Institutes of Health.
JAMA Netw Open. 2023 Jul 3;6(7):e2325342. doi: 10.1001/jamanetworkopen.2023.25342.
引用本文的文献
1
Publication of data sharing statements in clinical trials by cardiovascular journals: a quantitative and qualitative analysis.
Sci Data. 2025 Jul 15;12(1):1239. doi: 10.1038/s41597-025-05510-x.
2
Systematic reviewers' perspectives on sharing review data, analytic code, and other materials: A survey.
Cochrane Evid Synth Methods. 2023 Apr 10;1(2):e12008. doi: 10.1002/cesm.12008. eCollection 2023 Apr.
3
Guidance for systematic reviews in journal author instructions: Findings and recommendations for editorial teams.
Cochrane Evid Synth Methods. 2024 Mar 31;2(4):e12050. doi: 10.1002/cesm.12050. eCollection 2024 Apr.
4
Reducing risk of bias in interventional studies during their design and conduct: a scoping review.
BMC Med Res Methodol. 2025 Apr 1;25(1):85. doi: 10.1186/s12874-025-02467-8.
5
How do we measure the costs, benefits, and harms of sharing data from biomedical studies? A protocol for a scoping review.
Open Res Eur. 2025 Jan 14;3:151. doi: 10.12688/openreseurope.16063.2. eCollection 2023.
6
A scoping review of activities intended to reduce publication bias in randomised trials.
Syst Rev. 2024 Dec 20;13(1):310. doi: 10.1186/s13643-024-02728-5.
7
Bridging the gap: a translational perspective in spinal cord injury.
Exp Biol Med (Maywood). 2024 Sep 26;249:10266. doi: 10.3389/ebm.2024.10266. eCollection 2024.
8
Assessing transparency practices in dental randomized controlled trials.
BMC Med Res Methodol. 2024 Aug 24;24(1):185. doi: 10.1186/s12874-024-02316-0.
9
Open science practices in traditional, complementary, and integrative medicine research: A path to enhanced transparency and collaboration.
Integr Med Res. 2024 Jun;13(2):101047. doi: 10.1016/j.imr.2024.101047. Epub 2024 May 9.
10
Artificial general intelligence for radiation oncology.
Meta Radiol. 2023 Nov;1(3). doi: 10.1016/j.metrad.2023.100045. Epub 2023 Nov 24.
本文引用的文献
1
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.
BMJ. 2012 Jan 3;344:d7292. doi: 10.1136/bmj.d7292.
2
A model for dissemination and independent analysis of industry data.
JAMA. 2011 Oct 12;306(14):1593-4. doi: 10.1001/jama.2011.1459.
3
The International Stroke Trial database.
Trials. 2011 Apr 21;12:101. doi: 10.1186/1745-6215-12-101.
4
Sharing research data to improve public health.
Lancet. 2011 Feb 12;377(9765):537-9. doi: 10.1016/S0140-6736(10)62234-9. Epub 2011 Jan 7.
5
Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers.
BMJ. 2010 Jan 28;340:c181. doi: 10.1136/bmj.c181.
6
Neuraminidase inhibitors--the story behind the Cochrane review.
BMJ. 2009 Dec 8;339:b5164. doi: 10.1136/bmj.b5164.
7
Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance.
Arch Intern Med. 2009 Nov 23;169(21):1976-85. doi: 10.1001/archinternmed.2009.394.
8
Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.
PLoS Med. 2009 Sep;6(9):e1000144. doi: 10.1371/journal.pmed.1000144. Epub 2009 Sep 8.
9
Towards agreement on best practice for publishing raw clinical trial data.
Trials. 2009 Mar 18;10:17. doi: 10.1186/1745-6215-10-17.
10
Systematic review of the empirical evidence of study publication bias and outcome reporting bias.
PLoS One. 2008 Aug 28;3(8):e3081. doi: 10.1371/journal.pone.0003081.
Zotero 插件